ARTICLE | Clinical News
Reolysin pelareorep regulatory update
May 11, 2015 7:00 AM UTC
The European Commission and FDA granted Orphan Drug designation to Reolysin pelareorep from Oncolytics to treat pancreatic cancer and gastric cancer, respectively. The formulation of human reovirus ty...